Sinus Tarsi Injection Technique
Use ultrasound guidance with an anterolateral approach, inserting a 22-25 gauge needle out-of-plane from anterior to posterior, parallel to the calcaneal surface, targeting the mid-portion of the sinus tarsi using the frondiform ligament as your sonographic landmark 1, 2.
Why Ultrasound Guidance is Essential
Ultrasound guidance dramatically improves accuracy compared to landmark-based techniques. In cadaveric studies, US-guided sinus tarsi injections achieved 90% accuracy versus only 35% for non-guided injections 2. This matters clinically because accurate placement is critical for both diagnostic and therapeutic success. Ultrasound also allows real-time visualization of injectate flow and avoidance of neurovascular structures 3.
Patient Positioning and Equipment
- Position: Patient supine or lateral decubitus with the affected ankle accessible
- Transducer: High-frequency linear probe (17-5 MHz or similar) 4
- Needle: 22-25 gauge, 1.5 inch (38mm) to 2 inch (50mm) needle 4, 2
- Approach: Anterolateral, targeting the sinus tarsi between the talus and calcaneus
Step-by-Step Ultrasound Technique
Sonographic Landmark Identification
The frondiform ligament is your key landmark 1. This structure represents the three roots of the inferior extensor retinaculum arising from the sinus tarsi and appears as a distinct sling-like structure on ultrasound. Use this to reliably locate the sinus tarsi, particularly if you're less experienced with this injection.
Needle Trajectory
- Out-of-plane approach (needle perpendicular to transducer)
- Direction: Anterior to posterior, parallel to the calcaneal surface 4
- Insert through the anterolateral aspect of the ankle
- Advance toward the mid-portion of the sinus tarsi under continuous visualization
Volume and Medication
Studies demonstrate that 2-4 mL total volume is appropriate 4. At 2 mL, you'll distend the posterior recess; by 4 mL, both posterior and lateral recesses are adequately filled in all cases 4.
Medication options based on 2023 evidence 5:
- Corticosteroid + local anesthetic: Provides fastest initial improvement (superior at 1 and 3 months)
- Platelet-rich plasma (PRP): Slower onset but equivalent outcomes at 6 months
- Ozone: Similar efficacy profile to corticosteroid at 6 months
All three options provide clinically significant functional improvement for at least 6 months 5. Choose corticosteroid/anesthetic for rapid symptom relief; consider PRP or ozone for patients concerned about steroid effects or seeking regenerative approaches.
Critical Technical Points
Real-Time Monitoring
Scan while injecting to confirm injectate flow into the sinus tarsi and avoid extravasation into surrounding structures 2. You should visualize fluid distending the space between talus and calcaneus.
Structures to Avoid
- Peroneal tendon sheath (lies posterior and inferior)
- Neurovascular bundle
- Subtalar joint proper (unless specifically targeting it)
In cadaveric studies, proper US-guided technique placed zero injections into the peroneal sheath 4, demonstrating the safety of this approach when performed correctly.
Common Pitfalls
Inadequate visualization: If you cannot clearly identify the frondiform ligament and sinus tarsi anatomy, reposition the transducer or adjust gain settings before proceeding.
Confusing sinus tarsi with subtalar joint: The sinus tarsi is the space/tunnel between talus and calcaneus; the subtalar joint is the articulation itself. For sinus tarsi syndrome, target the mid-portion of the sinus tarsi space 2.
Insufficient volume: Using less than 2 mL may not adequately fill the space; 2-4 mL is the evidence-based range 4.
Blind injection: Non-guided sinus tarsi injections have a 65% miss rate 2. This is unacceptable for diagnostic or therapeutic purposes—always use ultrasound guidance.